Skip to main content
Clinical Trials/KCT0000105
KCT0000105
Completed
未知

The optimum bolus dose of remifentanil to faciliate intubating conditions with a single standard dose of propofol in elderly patients

Seoul National University Bundang Hospital0 sites30 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the blood and blood -forming organs and certain disorders involving the immune mechanism
Sponsor
Seoul National University Bundang Hospital
Enrollment
30
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • ASA class 1\-2
  • patients scheduled for elective surgery under tracheal intubation

Exclusion Criteria

  • suspected difficult airway
  • obese (BMI \> 30\)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
The optimum bolus dose of remifentanil to facilitate laryngeal mask airway insertion with a single standard dose of propofol in elderly patientsDiseases of the blood and blood -forming organs and certain disorders involving the immune mechanism
KCT0000088Seoul National University Bundang Hospital30
Completed
Phase 4
Effective dose of remifentanil for control of hemodynamic response to insertion of the Streamlined Liner of the Pharyngeal Airway(SLIPA)Hemodynamic response to insertion of the Streamlined Liner of the Pharyngeal Airway(SLIPA)Anaesthesiology - Other anaesthesiology
ACTRN12613000086763Chung-Ang University100
Active, not recruiting
Not Applicable
Study to evaluate the optimal dose of remifentanil infusion(effective dose in 80% of patients) required to ensure apnoea (of 30 seconds duration) during magnetic resonance imaging of the heart under general anaesthesia in children aged 1 to 6 years.Study refers to the use of this medicine during anaesthesia given during the investigation of congenital heart disease.Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2014-004346-10-GBAlder Hey Children's NHS Foundation Trust
Completed
Not Applicable
The Optimal Concentration of Remifentanil for the i-gel Insertion in Simulated Difficult Airway PatientsInjury, poisoning and certain other consequences of external causes
KCT0000924Hanyang University Guri Hospital47
Recruiting
Not Applicable
Determining the minimum dose required of Remifentanil to obtain adequate intubating conditions in children presenting for day case surgery - a randomised controlled trialAnaesthesia
PACTR201809879218534niversity of Pretoria Faculty of Health Sciences60